Fundz

Morphogenesis Inc reported raising $495,000 in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEJul 03, 2019$495K of $15M raised

Amount Raised

$495,000

$495,000 sold, per SEC Form D (first sale Jul 3, 2019)

Round Type

Seed

TampaBiotechnologyHealthcareHealth CareTherapeutics

Who to call at TuHURA Biosciences, and when

A new round usually means TuHURA Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TuHURA Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TuHURA Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TuHURA Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TuHURA Biosciences

Location

10500 University Center Drive

Tampa, Florida, United States

About

Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TuHURA Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsIan F., Senior Research Scientist hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for TuHURA Biosciences's next move

See what Strategic adds

TuHURA Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.